Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate

被引:9
|
作者
Wang, Xiaoli [1 ]
Wang, Jiao [2 ]
Zhang, Wenmei [1 ]
Li, Boye [1 ]
Zhu, Ying [1 ]
Hu, Qin [1 ]
Yang, Yishu [1 ]
Zhang, Xiaoguang [2 ]
Yan, Hong [1 ]
Zeng, Yi [2 ]
机构
[1] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China
[2] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China
来源
VIRUSES-BASEL | 2018年 / 10卷 / 05期
基金
中国国家自然科学基金;
关键词
human immunodeficiency virus type 1; Keggin polyoxometalate; entry inhibition; CD4; gp41; NHR; IN-VITRO; HIV-1; ENTRY; ANTIVIRAL ACTIVITY; REVERSE-TRANSCRIPTASE; ANTI-HIV-1; AGENTS; MULTIPLE STEPS; VIVO; REPLICATION; HPA-23; ASSAY;
D O I
10.3390/v10050265
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Here, we report the anti-human immunodeficiency virus (HIV) potency and underlying mechanisms of a Keggin polyoxometalate (PT-1, K6HPTi2W10O40). Our findings showed that PT-1 exhibited highly potent effects against a diverse group of HIV type 1 (HIV-1) strains and displayed low cytotoxicity and genotoxicity. The time-addition assay revealed that PT-1 acted at an early stage of infection, and these findings were supported by the observation that PT-1 had more potency against Env-pseudotyped virus than vesicular stomatitis virus glycoprotein (VSVG) pseudotyped virus. Surface plasmon resonance binding assays and flow cytometry analysis showed that PT-1 blocked the gp120 binding site in the CD4 receptor. Moreover, PT-1 bound directly to gp41 NHR (N36 peptide), thereby interrupting the core bundle formation of gp41. In conclusion, our data suggested that PT-1 may be developed as a new anti-HIV-1 agent through its effects on entry inhibition.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Inhibition of human immunodeficiency virus type 1 virion entry by dominant-negative Hck
    Tokunaga, K
    Kiyokawa, E
    Nakaya, M
    Otsuka, N
    Kojima, A
    Kurata, T
    Matsuda, M
    JOURNAL OF VIROLOGY, 1998, 72 (07) : 6257 - 6259
  • [2] Inhibition of human immunodeficiency virus type 1 entry by a binding domain of Porphyromonas gingivalis gingipain
    Xie, Hua
    Belogortseva, Natalya I.
    Wu, Jie
    Lai, Wei-Hong
    Chen, Chin-ho
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (09) : 3070 - 3074
  • [3] Influence of membrane fluidity on human immunodeficiency virus type 1 entry
    Harada, S
    Yusa, K
    Monde, K
    Akaike, T
    Maeda, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (02) : 480 - 486
  • [4] Replication of human immunodeficiency virus type 1 from entry to exit
    Lever, Andrew M. L.
    Jeang, Kuan-Teh
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 84 (01) : 23 - 30
  • [5] Replication of human immunodeficiency virus type 1 from entry to exit
    Andrew M. L. Lever
    Kuan-Teh Jeang
    International Journal of Hematology, 2006, 84 : 23 - 30
  • [6] Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis
    Maréchal, V
    Prevost, MC
    Petit, C
    Perret, E
    Heard, JM
    Schwartz, O
    JOURNAL OF VIROLOGY, 2001, 75 (22) : 11166 - 11177
  • [7] Mechanisms of human immunodeficiency virus type 1 inhibition by hydroxyurea
    Lori, F
    Lisziewicz, J
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1999, 13 (03): : 176 - 180
  • [8] Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides
    Egelhofer, M
    Brandenburg, G
    Martinius, H
    Schult-Dietrich, P
    Melikyan, G
    Kunert, R
    Baum, C
    Choi, I
    Alexandrov, A
    von Laer, D
    JOURNAL OF VIROLOGY, 2004, 78 (02) : 568 - 575
  • [9] Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1
    Yang, XZ
    Kurteva, S
    Ren, XP
    Lee, S
    Sodroski, J
    JOURNAL OF VIROLOGY, 2005, 79 (19) : 12132 - 12147
  • [10] Baseline susceptibility of primary human immunodeficiency virus type 1 to entry inhibitors
    Labrosse, B
    Labernardière, JL
    Dam, E
    Trouplin, V
    Skrabal, K
    Clavel, F
    Mammano, F
    JOURNAL OF VIROLOGY, 2003, 77 (02) : 1610 - 1613